[1]
Sanjay Kalra, Saptarshi Bhattacharya, and Nitin Kapoor, “Glucagon-Like Peptide 1 Receptor Agonists (GLP1RA) and Sodium-glucose co-transporter-2 inhibitors (SGLT2i): Making a pragmatic choice in diabetes management”, J Pak Med Assoc, vol. 72, no. 5, pp. 989–990, May 2022.